XBI ETF holdings (NYSE) - Page 4 | MetaTrader

Ver el calendario completo Full chart

Visión general Todos los activos Mapa de calor

Activos clave Market Value Shares Weight %

QURE uniQure NV 65.4 M 2.7 M 0.8%

APGE Apogee Therapeutics Inc 60.8 M 805.5 K 0.8%

VCYT Veracyte Inc 60.2 M 1.4 M 0.8%

RARE Ultragenyx Pharmaceutical Inc 60.2 M 2.6 M 0.8%

TWST Twist Bioscience Corp 60.1 M 1.9 M 0.8%

CPRX Catalyst Pharmaceuticals Inc 60.0 M 2.6 M 0.8%

SNDX Syndax Pharmaceuticals Inc 56.4 M 2.7 M 0.7%

IMVT Immunovant Inc 55.7 M 2.2 M 0.7%

DNLI Denali Therapeutics Inc 52.4 M 3.2 M 0.7%

VRDN Viridian Therapeutics Inc 51.4 M 1.7 M 0.7%

CLDX Celldex Therapeutics Inc 51.4 M 1.9 M 0.7%

BCRX BioCryst Pharmaceuticals Inc 49.4 M 6.3 M 0.6%

AGIO Agios Pharmaceuticals Inc 48.5 M 1.8 M 0.6%

IRON Disc Medicine Inc 47.5 M 598.0 K 0.6%

STOK Stoke Therapeutics Inc 47.4 M 1.5 M 0.6%

Dynavax Technologies Corp 46.9 M 3.0 M 0.6%

VCEL Vericel Corp 45.1 M 1.3 M 0.6%

MNKD MannKind Corp 42.5 M 7.5 M 0.5%

IMNM Immunome Inc 40.4 M 1.9 M 0.5%

JANX Janux Therapeutics Inc 40.1 M 2.9 M 0.5%

1
2
3
4
5
6
7
8

Noticias

First Quarter Earnings: Sharpening Sector Divergence

Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Biotech Investors Are Tuning Out the MAHA Chaos

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)

FDA Commissioner Marty Makary Expected To Resign, Ending Turbulent Stint

Why I Now Favor A Barbell Model Over Ray Dalio’s All-Weather Portfolio (SPY)

El interés corto en Intellia lidera el alza entre biotecnológicas según Baird

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone